The role of urethral dilation in managing pediatric neurogenic bladder dysfunction

被引:0
|
作者
Wan J. [1 ]
机构
[1] Department of Urology, University of Michigan, Ann Arbor, MI, 48109, 3875 Taubman 0330
关键词
Lower Urinary Tract Symptom; Neurogenic Bladder; Anticholinergic Medication; Clean Intermittent Catheterization; Leak Point Pressure;
D O I
10.1007/s11884-008-0020-9
中图分类号
学科分类号
摘要
Urethral dilation is an effective method of treating children with neurogenic bladders who have poor bladder compliance, high leak point pressure, and are unresponsive to standard therapy with anticholinergic medications and clean intermittent catheterization. Urethral dilation can be successfully applied to boys and girls and has few side effects. There are no demonstrated long-term effects on continence. However, the use of urethral dilation has been limited by two factors: 1) general disregard given to urethral dilation when applied to children and adults with recurrent urinary tract infections and lower urinary tract symptoms, and 2) the general efficacy of conventional therapy that limits the number of children who may actually benefit from the procedure. © 2008 Springer Science+Business Media, LLC.
引用
收藏
页码:127 / 132
页数:5
相关论文
共 50 条
  • [11] Management of pediatric neurogenic bladder
    MacLellan, Dawn L.
    CURRENT OPINION IN UROLOGY, 2009, 19 (04) : 407 - 411
  • [12] Drug Development for Pediatric Neurogenic Bladder Dysfunction: Dosing, Endpoints, and Study Design
    Momper, Jeremiah D.
    Karesh, Alyson
    Green, Dionna J.
    Hirsch, Mark
    Khurana, Mona
    Lee, Jinoo
    Kim, Myong-Jin
    Mulugeta, Yeruk
    Sachs, Hari C.
    Yao, Lynne
    Burckart, Gilbert J.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 54 (11) : 1239 - 1246
  • [13] Multicenter urethroplasty outcomes for urethral stricture disease for patients with neurogenic bladder or bladder dysfunction requiring clean intermittent catheterization
    Cohen, Andrew J.
    Cheng, Philip J.
    Song, Sikai
    Patino, German
    Myers, Jeremy B.
    Roy, Samit S.
    Elliott, Sean P.
    Pariser, Joseph
    Drobish, Justin
    Erickson, Brad A.
    Fuller, Thomas W.
    Buckley, Jill C.
    Vanni, Alex J.
    Baradaran, Nima
    Breyer, Benjamin N.
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2021, 10 (05) : 2035 - 2042
  • [14] OnabotulinumtoxinA is now an important tool for managing pediatric neurogenic lower urinary tract dysfunction
    Frainey, Brendan T.
    Clayton, Douglass B.
    FRONTIERS IN PEDIATRICS, 2024, 12
  • [15] Botulinum toxin for neurogenic bladder dysfunction
    Schulte-Baukloh, H.
    UROLOGE, 2012, 51 (02): : 198 - 203
  • [16] Conservative treatment of neurogenic bladder dysfunction
    Madersbacher, H
    UROLOGE A, 1999, 38 (01): : 24 - 29
  • [17] Botulinum toxin for neurogenic bladder dysfunction
    Schulte-Baukloh, H.
    UROLOGE, 2012, 51 (02): : 198 - 203
  • [18] Orthotopic neobladder for bladder cancer and neurogenic bladder dysfunction
    Maurice, Matthew J.
    Meeks, Joshua J.
    Smith, Norm D.
    CANADIAN JOURNAL OF UROLOGY, 2008, 15 (04) : 4194 - 4195
  • [19] Electrical stimulation in the treatment of neurogenic bladder dysfunction
    Al Mousa R.T.
    Hassouna M.M.
    Current Bladder Dysfunction Reports, 2008, 3 (4) : 195 - 202
  • [20] An animal model for the neuromodulation of neurogenic bladder dysfunction
    Zvara, P
    Sahi, S
    Hassouna, MM
    BRITISH JOURNAL OF UROLOGY, 1998, 82 (02): : 267 - 271